NO910163L - Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid. - Google Patents

Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid.

Info

Publication number
NO910163L
NO910163L NO91910163A NO910163A NO910163L NO 910163 L NO910163 L NO 910163L NO 91910163 A NO91910163 A NO 91910163A NO 910163 A NO910163 A NO 910163A NO 910163 L NO910163 L NO 910163L
Authority
NO
Norway
Prior art keywords
acid
nitroxylycyl
amid
pyridine
procedure
Prior art date
Application number
NO91910163A
Other languages
English (en)
Other versions
NO910163D0 (no
Inventor
Ekkehard Baader
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO910163D0 publication Critical patent/NO910163D0/no
Publication of NO910163L publication Critical patent/NO910163L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO91910163A 1990-01-16 1991-01-15 Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid. NO910163L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4001002A DE4001002A1 (de) 1990-01-16 1990-01-16 Pyridin-2,4-und 2,5-dicarbonsaeuredi-(nitroxyalkyl)amide, verfahren zu ihrer herstellung sowie deren verwendung

Publications (2)

Publication Number Publication Date
NO910163D0 NO910163D0 (no) 1991-01-15
NO910163L true NO910163L (no) 1991-07-17

Family

ID=6398117

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910163A NO910163L (no) 1990-01-16 1991-01-15 Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid.

Country Status (19)

Country Link
EP (1) EP0438795A1 (no)
JP (1) JPH04330060A (no)
KR (1) KR910014352A (no)
CN (1) CN1053606A (no)
AU (1) AU631285B2 (no)
BR (1) BR9100159A (no)
CA (1) CA2034206A1 (no)
CS (1) CS7591A2 (no)
DE (1) DE4001002A1 (no)
FI (1) FI910177A (no)
HU (1) HUT59102A (no)
IE (1) IE910126A1 (no)
IL (1) IL96941A0 (no)
MA (1) MA22041A1 (no)
MX (1) MX24143A (no)
NO (1) NO910163L (no)
NZ (1) NZ236766A (no)
PT (1) PT96493A (no)
ZA (1) ZA91291B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4020570A1 (de) 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
YU9492A (sh) * 1991-02-05 1995-03-27 Hoechst Ag. 2,4- i 2,5-bis-tetrazolilni piridini i postupak za njihovo dobijanje
EP0533130A1 (de) * 1991-09-19 1993-03-24 Hoechst Aktiengesellschaft 2-Hydroxymethylpyridine, die entsprechenden Pyridin-N-oxide und ihre Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung
EP0541042A1 (de) * 1991-11-05 1993-05-12 Hoechst Aktiengesellschaft Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509591B2 (en) * 1976-04-02 1980-05-15 Chugai Seiyaku Kabushiki Kaisha Pyridine derivatives
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen

Also Published As

Publication number Publication date
HU910109D0 (en) 1991-08-28
FI910177A (fi) 1991-07-17
CS7591A2 (en) 1991-09-15
IE910126A1 (en) 1991-07-17
HUT59102A (en) 1992-04-28
KR910014352A (ko) 1991-08-31
IL96941A0 (en) 1992-03-29
CA2034206A1 (en) 1991-07-17
CN1053606A (zh) 1991-08-07
NZ236766A (en) 1993-08-26
ZA91291B (en) 1991-09-25
MX24143A (es) 1993-05-01
PT96493A (pt) 1991-10-15
FI910177A0 (fi) 1991-01-14
JPH04330060A (ja) 1992-11-18
AU6936691A (en) 1991-07-18
NO910163D0 (no) 1991-01-15
MA22041A1 (fr) 1991-10-01
BR9100159A (pt) 1991-10-22
DE4001002A1 (de) 1991-07-18
AU631285B2 (en) 1992-11-19
EP0438795A1 (de) 1991-07-31

Similar Documents

Publication Publication Date Title
NO862899D0 (no) Granulert tilsetningsmiddel for vaskemidler, fremgangsmaate for fremstilling av dette og anvendelse av dette.
NO880558L (no) Pyridin-2,4- og 2,5-dikarboksylsyreamid, samt fremgangsmaate for fremstilling derav.
NO884835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-furo- og -tieno (2,3.-c) pyridiner.
NO885389D0 (no) Fremgangsmaate for fremstilling av immobilisert interleukin 2, og interleukin 2 inneholdende en carboxylterminal forlengelse.
NO823674L (no) Derivater av cis, endo-2-azabicyklo-(3.3.0)-oktan-3-3-karboksylsyrer, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
FI884497A (fi) Menetelmä uusien, aromataasia inhiboivien 4(5)-imidatsolien valmistamiseksi
TR28199A (tr) Herbisit tesirli piridinsülfonamid bilesimlerinin karisimlari.
DK178084D0 (da) 1,3-dihydro-6-methyl-7-hydrosyfuro-(3,4-c)-pyridinderivater og fremgangsmade til fremstilling deraf
NO884733L (no) Roermuffe og fremgangsmaate til fremstilling av samme.
NO880187L (no) Superledende forbindelser av den k2if4strukturelle typen med hoeyovergangstemperatur, og fremgangsmaate for deresfremstilling.
DK62288A (da) Substituerede 2,6-substituerede pyridinforbindelser og herbicide praeparater indeholdende disse forbindelser
NO880556L (no) Pyridin-2,4- og 2,5-dikarboksylsyrederivater, samt fremgangsmaater for fremstilling av forbindelsene.
DK281283A (da) 2,3-difluor-5-(trifluormethyl)pyridin og fremgangsmaader til fremstilling og anvendelse heraf
NO913834L (no) 4- eller 5-substituerte pyridin-2-karboksylsyrer og fremgangsmaate for fremstilling derav.
NO892499L (no) 2,5,6,7-tetranor-4,8-inter-m-fenylen pgi2 derivater, fremgangsmaate for fremstilling av disse, og anvendelse derav.
NO910163D0 (no) Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid.
DK0492667T3 (da) 1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse deraf
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
DK62388A (da) Substituerede 2,6-substituerede pyridinforbindelser og herbicide praeparater indeholdende disse forbindelser
EP0333020A3 (en) Process for the preparation of substituted pyridines
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
FI943833A0 (fi) Menetelmä 2,3,5,6-tetraklooripyridiinin valmistamiseksi
DK367388A (da) Fremgangsmaade til fremstilling af hoejredrejende 3-(3-pyridyl)-1h,3h-pyrrolo oe1,2-caathiazol-7-carboxylsyre
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.